ARC logo.png
Mesenchymal Stem Cells Market Value Projected To Reach US$ 2,600.5 Million By 2027 Covering Pre and Post COVID-19 Market Analysis: Acumen Research and Consulting
19 mai 2021 11h34 HE | Acumen Research and Consulting
LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) -- The Global Mesenchymal Stem Cells Market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and reach the market value of over US$ 2,600.5...
Sorrento Announces Updated Positive Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
25 mars 2021 15h58 HE | Sorrento Therapeutics, Inc.
All nine patients with acute respiratory failure due to COVID-19 discharged from hospital within days after 3rd COVI-MSC infusionPreparations are ongoing for initiating Phase 2 placebo-controlled...
Graphical Research.jpg
Bioreactors Market Trends 2021 | North America, Europe, & APAC Industry Forecasts 2026: Graphical Research
11 mars 2021 05h00 HE | Graphical Research
Pune, India, March 11, 2021 (GLOBE NEWSWIRE) -- The global bioreactors market is predicted to witness substantial growth rate during the forecast period. With the augmented demand for the...
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
26 janv. 2021 19h09 HE | Sorrento Therapeutics, Inc.
First three patients discharged from Hospital ICU within 8 days from initial IV administration  No infusion-related adverse events noted for any patient treated to date  SAN DIEGO, Jan. 26, 2021 ...
IMAC Holdings to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
05 janv. 2021 09h00 HE | IMAC Holdings, Inc.
BRENTWOOD, Tenn., Jan. 05, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative...
High res JPG file 2 (2).jpg
FibroGenesis Named Top 20 Most Innovative Companies of 2020 and Lands at the #2 Spot on Global Smart Leaders Magazine List
08 oct. 2020 10h07 HE | FibroGenesis
HOUSTON, Oct. 08, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, the leading developer of fibroblast based therapeutic solutions for unmet medical needs, is proud to announce Global Smart Leaders Magazine...
High res JPG file 2 (2).jpg
FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting
12 août 2020 10h07 HE | FibroGenesis
HOUSTON, Aug. 12, 2020 (GLOBE NEWSWIRE) -- FibroGenesis, a clinical stage company developing fibroblast based therapeutic solutions for unmet medical needs, announced today new data supporting...
Reports and Data.jpeg-01
Cancer Stem Cells Market To Reach USD 2.18 Billion By 2027 | Reports and Data
14 mai 2020 11h06 HE | Reports and Data
New York, May 14, 2020 (GLOBE NEWSWIRE) -- The global Cancer Stem Cells market is forecast to reach USD 2.18 Billion by 2027, according to a new report by Reports and Data. The market for stem cells...
Stem Cell Network Warns that Claims of Stem Cell Treatments for COVID-19 Are Unfounded and Misleading
31 mars 2020 15h09 HE | Stem Cell Network
OTTAWA, March 31, 2020 (GLOBE NEWSWIRE) -- In recent weeks, a number of claims have been made that stem cells can be used as a treatment for the coronavirus disease (COVID-19). Globally, there is no...
BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn® Regulatory Pathway for Approval in ALS
11 févr. 2020 06h00 HE | BrainStorm Cell Therapeutics Inc.
NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics, Inc., (NASDAQ:BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that...